Last reviewed · How we verify
Octestrol (BENZESTROL)
Octestrol (generic name: BENZESTROL) is a benzestrol drug. It is currently in Phase 2 development.
Benzestrol is thought to work by binding to estrogen receptors, mimicking the effects of estrogen in the body.
Octestrol, also known as Benzestrol, is a small molecule drug in the benzestrol class. Its exact target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand the potential benefits and risks of this compound. Due to its lack of FDA approval and limited information, it is not currently available as a prescription medication.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | BENZESTROL |
|---|---|
| Drug class | benzestrol |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 2 |
Mechanism of action
Imagine your body has locks on the door of cells that only estrogen can open. Benzestrol is a key that fits into those locks, allowing it to enter the cell and trigger a response. This can affect various bodily functions, but the exact details of how it works are still unclear.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Octestrol CI brief — competitive landscape report
- Octestrol updates RSS · CI watch RSS
Frequently asked questions about Octestrol
What is Octestrol?
How does Octestrol work?
What is the generic name of Octestrol?
What drug class is Octestrol in?
What development phase is Octestrol in?
Related
- Drug class: All benzestrol drugs
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing